Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 2 | +5K | 100% | $0.50 | +$2.48K |
Sells | 0 | ||||
Net | +2 | +5K | 100% | +$2.48K |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Vivo Capital VIII, LLC | 10%+ Owner | $5.44M | Nov 21, 2023 | ||
Novo Holdings A/S | 10%+ Owner | $3.52M | Jul 13, 2022 | ||
Edgar Engleman | Director | $1.97M | Nov 29, 2023 | ||
Edith A. Perez | Chief Medical Officer | $36.5K | Mar 4, 2024 | ||
William P. Quinn | President, CEO and CFO, Director | $24.7K | +$1.24K | +5.29% | May 1, 2025 |
Randall C. Schatzman | Chief Executive Officer, Director | $10.1K | Mar 4, 2024 | ||
Sarah Nemec | Senior VP, Finance and PAO | $8.84K | +$1.24K | +16.3% | May 1, 2025 |
Kathleen Laporte | Director | May 27, 2025 | |||
Grant Yonehiro | Chief Operating Officer | May 1, 2025 | |||
Brian O'callaghan | Director | May 27, 2025 | |||
Frank D. Lee | Director | Jun 12, 2024 | |||
Mahendra Shah | Director | Jun 12, 2024 | |||
Jakob Dupont | Director | May 27, 2025 | |||
David Dornan | Chief Scientific Officer | Feb 18, 2022 | |||
Laura Berner | Director | May 27, 2025 | |||
Richard A. Miller | Director | Jun 12, 2023 | |||
Nicole Onetto | Director | May 27, 2025 | |||
James Healy | Director | Jun 12, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|